Comparative Activity of Piperacillin/Tazobactam against Clinical Isolates of Extended- Spectrum [beta]-Lactamase-Producing Enterobacteriaceae
[beta]-Lactam resistance on the part of the Enterobacteriaceae causes serious therapeutic problems in our institutions due to their production of extended-spectrum [beta]-lactamases (ES[beta]Ls). We studied the in vitro activity of [beta]-lactam/[beta]-lactamase inhibitor combinations and third-gene...
Gespeichert in:
Veröffentlicht in: | Chemotherapy (Basel) 1998-11, Vol.44 (6), p.377 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [beta]-Lactam resistance on the part of the Enterobacteriaceae causes serious therapeutic problems in our institutions due to their production of extended-spectrum [beta]-lactamases (ES[beta]Ls). We studied the in vitro activity of [beta]-lactam/[beta]-lactamase inhibitor combinations and third-generation cephalosporins and monobactams against 71 clinically relevant Enterobacteriaceae which produced TEM- and SHV-derivative ES[beta]Ls. Of the single drugs and combinations tested, piperacillin/tazobactam proved to be the most effective. Piperacillin/tazobactam was highly active against |
---|---|
ISSN: | 0009-3157 1421-9794 |